Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Brandt Kevin D
 2. Date of Event Requiring Statement (Month/Day/Year)
12/13/2016		 3. Issuer Name and Ticker or Trading Symbol
RTI SURGICAL, INC. [RTIX]
(Last)
(First)
(Middle)
11621 RESEARCH CIRCLE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
Vice President and GM
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

ALACHUA, FL 32615		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 30,585 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase Common Stock, $.001 par value per share   (2) 07/16/2022 Common Stock, par value $.001 60,000 $ 3.5 D  
Option to purchase Common Stock, $.001 par value per share   (3) 02/25/2023 Common Stock, par value $.001 40,000 $ 3.6 D  
Option to purchase Common Stock, $.001 par value per share   (4) 02/25/2024 Common Stock, par value $.001 20,000 $ 3.78 D  
Option to purchase Common Stock, $.001 par value per share   (5) 02/17/2025 Common Stock, par value $.001 20,000 $ 5.23 D  
Option to purchase Common Stock, $.001 par value per share   (6) 02/24/2026 Common Stock, par value $.001 38,710 $ 3.31 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Brandt Kevin D
11621 RESEARCH CIRCLE
ALACHUA, FL 32615		       Vice President and GM

Signatures

/s/Kevin D. Brandt 12/20/2016
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This contains 12,085 Restricted Stock Awards that will vest as to 4,029 on 2/24/2017 and 4,028 on each of 2/24/2018 and 2/24/2019.
(2) Consist of 48,000 fully vested and exercisable options and 12,000 unvested options that will vest and become exercisable on 7/16/2017.
(3) Consist of 24,000 fully vested and exercisable options and 16,000 unvested options that will vest and become exercisable as to 8,000 on each of 2/25/2017 and 2/25/2018.
(4) Consist of 8,000 fully vested and exercisable options and 12,000 unvested options that will vest and become exercisable as to 4,000 shares on each of 2/25/2017, 2/25/2018 and 2/25/2019.
(5) Consist of 4,000 fully vested and exercisable options and 16,000 unvested options that will vest and become exercisable as to 4,000 shares on each of 2/17/2017, 2/17/2018, 2/17/2019 and 2/17/2020.
(6) This option will become exercisable as to 7,742 shares on each of 2/24/2017, 2/24/2018, 2/24/2019, 2/24/2020 and 2/24/2021.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.